Saniona AB

Saniona AB (publ) is a clinical-stage biopharmaceutical company focused on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders. It operates in Ireland, the United States, Germany, Denmark, and the United Kingdom, and also develops medicines that modulate ion channels. Its product pipeline includes Tesofensine, Tesomet, ACP-711, SAN903, SAN2219, SAN2355, SAN2668, and SAN2465. The company has research and collaboration agreements with Boehringer Ingelheim International GmbH, Productos Medix, S.A. de C.V., Cephagenix ApS, and AstronauTx. Founded in 2011, Saniona AB is headquartered in Glostrup, Denmark.